372
Views
14
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

, , , , , , , , , , , , , , , , , & show all
Pages 1007-1012 | Received 23 Mar 2013, Accepted 15 Jul 2013, Published online: 16 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Montserrat López-Rubio & Jose Antonio Garcia-Marco. (2015) Current and emerging treatment options for hairy cell leukemia. OncoTargets and Therapy 8, pages 2147-2156.
Read now
Zheng Z Topp & Alan Saven. (2014) Hairy cell leukemia: a ‘hair-raising’ update. Expert Review of Hematology 7:5, pages 659-669.
Read now
Jae H. Park & Martin S. Tallman. (2014) Left behind: should minimal residual disease be treated in hairy cell leukemia?. Leukemia & Lymphoma 55:5, pages 971-972.
Read now

Articles from other publishers (11)

Jérôme Paillassa, Elsa Maitre & Xavier Troussard. (2022) Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances. Current Oncology Reports 24:9, pages 1133-1143.
Crossref
Alessandro Broccoli, Lisa Argnani, Matthew Cross, Agnieszka Janus, Elsa Maitre, Xavier Troussard, Tadeusz Robak, Claire Dearden, Monica Else, Daniel Catovsky & Pier Luigi Zinzani. (2022) A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia. Blood Advances 6:14, pages 4224-4227.
Crossref
Jérôme Paillassa & Xavier Troussard. (2021) Patients with relapsed/refractory hairy‐cell leukemia. Cancer Reports 5:3.
Crossref
Jan-Paul Bohn, Sabrina Neururer, Markus Pirklbauer, Andreas Pircher & Dominik Wolf. (2022) Hairy Cell Leukemia Patients Have a Normal Life Expectancy—A 35-Year Single-Center Experience and Comparison with the General Population. Cancers 14:5, pages 1242.
Crossref
Jan-Paul Bohn & Sascha Dietrich. (2022) Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine. Cancers 14:4, pages 956.
Crossref
Raheel Siddiqui, Muhammad Sardar, Moazzam Shahzad, Jemin Jose, Insija Selene, Zunaira Shah, Anum Qureshi, Madeeha Shafqat, Rimsha Kashif, Maheen Ahmad, Alex Mejia-Garcia & Faiz Anwer. (2021) Management of Relapsed Hairy Cell Leukemia: A Systematic Review of Novel Agents and Targeted Therapies. Clinical Lymphoma Myeloma and Leukemia 21:10, pages 659-666.
Crossref
Jerome Paillassa, Edouard Cornet, Stephanie Noel, Cecile Tomowiak, Stephane Lepretre, Sandrine Vaudaux, Jehan Dupuis, Alain Devidas, Bertrand Joly, Charlotte Petitdidier-Lionnet, Stephanie Haiat, Clara Mariette, Catherine Thieblemont, Didier Decaudin, Patricia Validire-Charpy, Bernard Drenou, Jean-Claude Eisenmann, Mario Ojeda Uribe, Agnès Olivrie, Mohamed Touati, Olivier Lambotte, Olivier Hermine, Jean-Michel Karsenti, Pierre Feugier, Willy Vaillant, Jean Gutnecht, Eric Lippert, Fabienne Huysman, Kamel Ghomari, Marouane Boubaya, Vincent Levy, Jeremie Riou, Gandhi Damaj, Aline Tanguy-Schmidt, Mathilde Hunault-Berger & Xavier Troussard. (2020) Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up. Blood Cancer Journal 10:5.
Crossref
Sonia Ali & Alan Saven. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 135 152 .
Victoria Divino, Sudeep Karve, Andrew Gaughan, Mitch DeKoven, Guozhi Gao, Kevin B Knopf & Mark C Lanasa. (2017) Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis. Journal of Comparative Effectiveness Research 6:6, pages 497-508.
Crossref
Bartlomiej M. Getta, Jae H. Park & Martin S. Tallman. (2015) Hairy cell leukemia: Past, present and future. Best Practice & Research Clinical Haematology 28:4, pages 269-272.
Crossref
Monica Else, Claire E. Dearden & Daniel Catovsky. (2015) Long-term follow-up after purine analogue therapy in hairy cell leukaemia. Best Practice & Research Clinical Haematology 28:4, pages 217-229.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.